• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Tata Power Co. Ltd. Dec 11

  • ID: 2030049
  • December 2011
  • Standard & Poors

FEATURED COMPANIES

  • Jaguar Land Rover Ltd.
  • Land Rover
  • Land Rover Exports Ltd.
  • Tata Motors Ltd.
  • Tata Power Co. Ltd.
  • Tata Steel Ltd.
  • MORE

Abstract
The company's financial risk profile is aggressive due to high financial leverage. Its exposure to counterparty risks is increasing. Operating efficiency is improving and project completion risk has decreased. The company has a good customer profile and a strong competitive position in core licensed operations. Our outlook on power demand in India is positive overall. The rating on Tata Power reflects the company's aggressive financial risk profile, high debt leverage, increasing exposure to competitive generation projects, and residual completion risk at a Mundra project. Tata Power's good operating efficiency, the competitive position of the company's core licensed operations, and our positive outlook on electricity demand in India temper these weaknesses. We believe Tata Power's capital expenditure will remain significant for...

Companies mentioned in this report are:
- Tata Power Co. Ltd.
- Tata Motors Ltd.
- Tata Steel Ltd.
- Tata Steel UK Holdings Ltd.
- Tata Consultancy Services Ltd.
- Jaguar Land Rover Automotive PLC
- Land Rover Exports Ltd.
- Jaguar Land Rover Exports Ltd.
- Jaguar Land Rover North America LLC
- Land Rover
- READ MORE >

Note: Product cover images may vary from those shown

- Tata Power Co. Ltd.
- Tata Motors Ltd.
- Tata Steel Ltd.
- Tata Steel UK Holdings Ltd.
- Tata Consultancy Services Ltd.
- Jaguar Land Rover Automotive PLC
- Land Rover Exports Ltd.
- Jaguar Land Rover Exports Ltd.
- Jaguar Land Rover North America LLC
- Land Rover
- Jaguar Land Rover Ltd.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.